Azole therapy of clinical and experimental coccidioidomycosis

Annals of the New York Academy of Sciences

Volumn 1111, Issue , 2007, Pages 442-454

  Stevens, David A ^a   Clemons, Karl V ^b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Azole antifungals; Clinical coccidioidomycosis therapy; Experimental coccidioidomycosis therapy

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POSACONAZOLE; PYRROLE;

ABDOMINAL PAIN; ALOPECIA; ANEMIA; ANOREXIA; ANTIMICROBIAL ACTIVITY; ARTHRALGIA; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; CONFERENCE PAPER; CONSTIPATION; DIARRHEA; DIZZINESS; ENCEPHALITIS; FATIGUE; FEVER; GASTRITIS; GYNECOMASTIA; HAIR LOSS; HEADACHE; HEART INFARCTION; HUMAN; HYPONATREMIA; IMPOTENCE; LIBIDO; LIVER DYSFUNCTION; MALAISE; MENSTRUAL IRREGULARITY; MYCOSIS; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PATHOGENESIS; PELVIS PAIN SYNDROME; PHLEBITIS; POLYDIPSIA; PREMATURE EJACULATION; PRURITUS; RASH; SIDE EFFECT; THROMBOCYTOSIS; TINNITUS; TREMOR; VOMITING; WEAKNESS; WEIGHT REDUCTION;

EID: 35348874220     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1406.039     Document Type: Conference Paper

References (26)

1. LEVINE, H.B., D.A. STEVENS, J.H. COBB, et al. 1975. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J. Infect. Dis. 132: 407-414.
2. STEVENS, D.A. 1977. The role of miconazole in systemic fungal infections. Am. Rev. Resp. Dis. 116: 801-806.
3. BORELLI, D., J.L. BRAN, J. FUENTES, et al. 1979. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad. Med. J. 55: 657-661.
4. STEVENS, D.A., R.L. STILLER, P.L. WILLIAMS, et al. 1983. Experience with ketoconazole in three major presentations of progressive coccidioidomycosis. Am. J. Med. 74: 58-63.
5. SUGAR, A.M., S.G. ALSIP, J.N. GALGIANI, et al. 1987. Pharmacology and toxicity of high dose ketoconazole. Antimicrob. Agents Chemother. 31: 1874-1878.
6. STEVENS, D.A. 1985. Ketoconazole metamorphosis: an antimicrobial becomes an endocrine drug. Arch. Intern. Med. 145: 813-815.
7. GANER, A., E. ARATHOON & D.A. STEVENS. 1987. Initial experience in therapy of progressive mycoses with itraconazole, the first triazole in clinical studies. Rev. Infect. Dis. 9: S77-S86.
8. TUCKER, R.M., D.W. DENNING, E.G. ARATHOON, et al. 1990. Itraconazole therapy of nonmeningeal coccidioidomycosis: clinical and laboratory observations. J. Am. Acad. Derm. 23: 593-601.
9. STEVENS, D.A. 1999. Itraconazole in cyclodextrin solution. Pharmacotherapy 19: 603-611.
10. TUCKER, R.M., Y. HAQ, D.W. DENNING, et al. 1990. The toxicity of itraconazole in 189 patients on chronic therapy. J. Antimicrob. Chemother. 26: 561-566.
11. TUCKER, R.M., D.W. DENNING, L.H. HANSON, et al. 1992. The interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin. Infect. Dis. 14: 165-174.
12. TUCKER, R.M., D.W. DENNING, B. DUPONT, et al. 1990. Itraconazole therapy of chronic coccidioidal meningitis. Ann. Intern. Med. 112: 108-112.
13. DIAZ, M., R. NEGRONI, F. MONTERO-GEI, et al. 1992.APanamerican five year study of fluconazole therapy of deepmycoses in the noncompromised host. Clin. Infect. Dis. 14(Suppl. 1): S68-S76.
14. CATANZARO, A., J.N. GALGIANI, B.E. LEVINE, et al. 1995. Fluconazole in the treatment of pulmonary and nonmeningeal coccidioidomycosis. Am. J. Med. 98: 249-256.
15. STEVENS, D.A., M. DIAZ, R. NEGRONI, et al. 1997. Safety evaluation of chronic fluconazole therapy. Chemotherapy 43: 371-377.
16. TUCKER, R.M., J.N. GALGIANI, D.W. DENNING, et al. 1990.Treatment of coccidioidal meningitis with fluconazole. Rev. Infect. Dis. 12: S380-S389.
17. DEWSNUP, D.H., J.N. GALGIANI, J.R. GRAYBILL, et al. 1996. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann. Intern. Med. 124: 305-310.
18. GALGIANI, J.N., A. CATANZARO, G.A. CLOUD, et al. 2000. Randomized double-blind comparison of oral fluconazole and itraconazole for progressive nonmeningeal coccidioidomycosis. Ann. Intern. Med. 133: 676-686.
19. SORENSEN, K.N., R.A. SOBEL, K.V. CLEMONS, et al. 2000. Comparison of fluconazole and itraconazole in the treatment of experimental coccidioidal meningitis in a rabbit model. Antimicrob. Agents Chemother. 44: 1512-1517.
20. KAMBERI, P., R.A. SOBEL, K.V. CLEMONS, et al. 2007. Comparison of itraconazole and fluconazole against coccidioidal meningitis in a murine model. Antimicrob. Agents Chemother. 51: 998-1063.
21. PROIA, L.A. & A.R. TENORIO. 2004. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother. 48: 2341.
22. ANTONY, S.J., P. JURCZYK & L. BRUMBLE. 2006. Successful use of combination antifungal therapy in the treatment of Coccidioides meningitis. J. Natl. Med. Assoc. 98: 940-942.
23. PRABHU, R.M., M. BONNELL, B.L. CURRIER, et al. 2004. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin. Infect. Dis. 39: e74-e77.
24. CORTEZ, K.J., T.J. WALSH & J.E. BENNETT. 2003. Successful treatment of coccidioidal meningitis with voriconazole. Clin. Infect. Dis. 36: 1619-1622.
25. LUTZ, J.E., K.V. CLEMONS, B.H. ARISTIZABAL, et al. 1997. Activity of the triazole SCH56592 against disseminated murine coccidioidomycosis. Antimicrob. Agents Chemother. 41: 1558-1561.
26. STEVENS, D.A. 1997. Azoles in the treatment of coccidioidomycosis. In: Proceedings of the Centennial Conference on Coccidioidomycosis, H.E. Einstein, D. Pappagianis, A. Catanzaro, Eds.: 255-264. Nat. Foundation for Infectious Diseases.